Loading clinical trials...
Loading clinical trials...
Satisfaction and Treatment Experiences With RitlEcitiNib And Traditional Treatments for Severe Alopecia Areata Among Adults in the United States (SERENATA)
Conditions
Interventions
Ritlecitinib
Locations
1
United States
Pfizer
New York, New York, United States
Start Date
February 3, 2025
Primary Completion Date
May 30, 2025
Completion Date
May 30, 2025
Last Updated
September 30, 2025
NCT07029711
NCT07152119
NCT07029828
NCT06562894
Lead Sponsor
Pfizer
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions